Comparative Effectiveness of a Lymph Node Collection Kit Versus Heightened Awareness on Lung Cancer Surgery Quality and Outcomes
- PMID: 33588112
- PMCID: PMC8084985
- DOI: 10.1016/j.jtho.2021.01.1618
Comparative Effectiveness of a Lymph Node Collection Kit Versus Heightened Awareness on Lung Cancer Surgery Quality and Outcomes
Abstract
Introduction: The adverse prognostic impact of poor pathologic nodal staging has stimulated efforts to heighten awareness of the problem through guidelines, without guidance on processes to overcome it. We compared heightened awareness (HA) of nodal staging quality versus a lymph node collection kit.
Methods: We categorized curative-intent lung cancer resections from 2009 to 2020 in a population-based, nonrandomized stepped-wedge implementation study of both interventions, into preintervention baseline, HA, and kit subcohorts. We used differences in proportion and hazard ratios across the subcohorts to estimate the effect of the interventions on poor quality (nonexamination of nodes [pNX] or nonexamination of mediastinal lymph nodes) and attainment of quality recommendations of the National Comprehensive Cancer Network, the Commission on Cancer, and the proposed complete resection definition of the International Association for the Study of Lung Cancer across the three cohorts.
Results: Of 3734 resections, 39% were preintervention, 40% kit, and 21% HA cases. Cohort proportions were the following: pNX, 11% (baseline) versus 0% (kit) versus 9% (HA); nonexamination of mediastinal lymph nodes, 27% versus 1% versus 22%; Commission on Cancer benchmark attainment, 14% versus 77% versus 30%; International Association for the Study of Lung Cancer-defined complete resection, 11% versus 58% versus 24%; National Comprehensive Cancer Network attainment, 23% versus 79% versus 35% (p < 0.001 for all, except pNX rate baseline versus HA). Survival rate was significantly higher for both interventions compared with baseline (p < 0.0001).
Conclusions: Resections with HA or the kit significantly improved surgical quality and outcomes, but the kit was more effective. We propose to conduct a prospective, institutional cluster-randomized clinical trial comparing both interventions.
Keywords: American College of Surgeons Operative Standard 5.8; Heightened awareness; Lymph node specimen collection kit; Quality of care; Surgical resection.
Copyright © 2021 International Association for the Study of Lung Cancer. Published by Elsevier Inc. All rights reserved.
Figures
Similar articles
-
Institution-Level Evolution of Lung Cancer Resection Quality With Implementation of a Lymph Node Specimen Collection Kit.J Thorac Oncol. 2023 Jul;18(7):858-868. doi: 10.1016/j.jtho.2023.03.002. Epub 2023 Mar 15. J Thorac Oncol. 2023. PMID: 36931504 Free PMC article.
-
Outcomes After Use of a Lymph Node Collection Kit for Lung Cancer Surgery: A Pragmatic, Population-Based, Multi-Institutional, Staggered Implementation Study.J Thorac Oncol. 2021 Apr;16(4):630-642. doi: 10.1016/j.jtho.2020.12.025. Epub 2021 Feb 16. J Thorac Oncol. 2021. PMID: 33607311 Free PMC article.
-
Effectiveness of Implemented Interventions on Pathologic Nodal Staging of Non-Small Cell Lung Cancer.Ann Thorac Surg. 2018 Jul;106(1):228-234. doi: 10.1016/j.athoracsur.2018.02.021. Epub 2018 Mar 11. Ann Thorac Surg. 2018. PMID: 29534956 Free PMC article.
-
Surgical assessment and intraoperative management of mediastinal lymph nodes in non-small cell lung cancer.Ann Thorac Surg. 2007 Sep;84(3):1059-65. doi: 10.1016/j.athoracsur.2007.04.032. Ann Thorac Surg. 2007. PMID: 17720443 Review.
-
Current status of mediastinal lymph node dissection versus sampling in non-small cell lung cancer.Thorac Surg Clin. 2013 Aug;23(3):349-56. doi: 10.1016/j.thorsurg.2013.05.002. Epub 2013 Jul 16. Thorac Surg Clin. 2013. PMID: 23931018 Review.
Cited by
-
Influencing Factors on the Quality of Lymph Node Dissection for Stage IA Non-Small Cell Lung Cancer: A Retrospective Nationwide Cohort Study.Cancers (Basel). 2024 Jan 13;16(2):346. doi: 10.3390/cancers16020346. Cancers (Basel). 2024. PMID: 38254835 Free PMC article.
-
Two Interventions on Pathologic Nodal Staging in a Population-Based Lung Cancer Resection Cohort.Ann Thorac Surg. 2024 Mar;117(3):576-584. doi: 10.1016/j.athoracsur.2023.08.026. Epub 2023 Sep 5. Ann Thorac Surg. 2024. PMID: 37678613 Free PMC article.
-
Rates of Guideline-Concordant Surgery and Adjuvant Chemotherapy Among Patients With Early-Stage Lung Cancer in the US ALCHEMIST Study (Alliance A151216).JAMA Oncol. 2022 May 1;8(5):717-728. doi: 10.1001/jamaoncol.2022.0039. JAMA Oncol. 2022. PMID: 35297944 Free PMC article.
-
Institution-Level Evolution of Lung Cancer Resection Quality With Implementation of a Lymph Node Specimen Collection Kit.J Thorac Oncol. 2023 Jul;18(7):858-868. doi: 10.1016/j.jtho.2023.03.002. Epub 2023 Mar 15. J Thorac Oncol. 2023. PMID: 36931504 Free PMC article.
-
A Comprehensive Comparison of Different Nodal Subclassification Methods in Surgically Resected Non-Small-Cell Lung Cancer Patients.Ann Surg Oncol. 2022 Dec;29(13):8144-8153. doi: 10.1245/s10434-022-12363-w. Epub 2022 Aug 18. Ann Surg Oncol. 2022. PMID: 35980551 Review.
References
-
- Pfannschmidt J, Muley T, Bulzebruck H, Hoffmann H, Dienemann H. Prognostic assessment after surgical resection for non-small cell lung cancer: experiences in 2083 patients. Lung Cancer 55:371–377, 2007 - PubMed
-
- Asamura H, Chansky K, Crowley J, et al. The International Association for the Study of Lung Cancer Lung Cancer staging project: proposals for the revision of the N descriptors in the forthcoming 8th edition of the TNM classification for lung cancer. J Thorac Oncol 10:1675–1684, 2015 - PubMed
-
- Arriagada R, Bergman B, Dunant A, Le Chevalier T, Pignon JP, Vansteenkiste J; International Adjuvant Lung Cancer Trial Collaborative Group. Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer. N Engl J Med. 2004. January 22;350(4):351–60. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical